Aurora Cannabis Inc. (ACB)
NASDAQ: ACB · Real-Time Price · USD
5.19
-0.05 (-0.95%)
At close: Nov 5, 2026, 4:00 PM EST
5.17
-0.02 (-0.39%)
After-hours: Nov 5, 2026, 7:59 PM EST
Aurora Cannabis Revenue
Aurora Cannabis had revenue of 67.55M CAD in the quarter ending June 30, 2026, a decrease of -8.80%. This brings the company's total for the last twelve months to 314.07M, up 12.35% year-over-year. In the fiscal year ending March 31, 2026, Aurora Cannabis had annual revenue of 320.59M with 10.97% growth.
Revenue (ttm)
314.07M CAD
Revenue Growth
+12.35%
P/S Ratio
1.55
Revenue / Employee
305,517 CAD
Employees
1,028
Market Cap
342.54M USD
Revenue by Geography
- Canada 144.07M 44.9%
- Europe 131.84M 41.1%
- Australia 39.04M 12.2%
- New Zealand 5.65M 1.8%
Fiscal year ended Mar 31, 2026 See the full Aurora Cannabis breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 320.59M | 31.68M | 10.97% |
| Mar 31, 2025 | 288.91M | 19.27M | 7.15% |
| Mar 31, 2024 | 269.64M | 45.83M | 20.48% |
| Mar 31, 2023 | 223.80M | 2.47M | 1.11% |
| Jun 30, 2022 | 221.34M | -23.91M | -9.75% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Tilray Brands | 963.10M |
| Emergent BioSolutions | 649.10M |
| Akebia Therapeutics | 219.06M |
| Canopy Growth | 206.77M |
| Kamada | 191.85M |
| Glass House Brands | 176.98M |
| Lifecore Biomedical | 129.46M |
| Anika Therapeutics | 120.65M |
ACB News
- 7 hours ago - Aurora Cannabis Announces Fiscal 2027 Second Quarter Results and Organigram Acquisition Agreement - Nasdaq
- 16 hours ago - Aurora Cannabis MD&A: Q2 2027 - Filings
- 16 hours ago - Aurora Cannabis Report: Q2 2027 - Filings
- 16 hours ago - Aurora Cannabis Earnings release: Q2 2027 - Filings
- 16 hours ago - Aurora Cannabis Earnings release: Q2 2027 - Filings
- 17 hours ago - Aurora Cannabis reports Q2 revenue C$86.021M vs C$78.8M last year - TheFly
- 18 hours ago - Aurora Cannabis Announces Fiscal 2027 Second Quarter Results - Business Wire
- 1 day ago - Aurora Cannabis Inc. Enters into Arrangement Agreement to be Acquired by Organigram Global Inc. for C$7.80 Per Share - Nasdaq